Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system.

Abbey C SidebottomMarc C VacquierJoseph C JensenSteven M BradleyThomas KnickelbineCraig StraussMichael D Miedema

Published in: Clinical cardiology (2020)

In a large health system, guideline-based statin use has remained suboptimal. Improved strategies are needed to increase statin utilization in appropriate patients.

Keyphrases

end stage renal disease
cardiovascular disease
ejection fraction
coronary artery disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
stem cells
mesenchymal stem cells
fatty acid
low density lipoprotein
cell therapy